Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO)

Measuring Silent Disease Progression in Multiple Sclerosis With a Multimodal Approach

NCT06501950 ·Status: RECRUITING

Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta

NCT00819897 ·Status: TERMINATED

Combined Analysis of Inflammatory Biomarkers for CNS Autoimmune Diseases Diagnostic

NCT05056740 ·Status: RECRUITING

Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset

NCT04466150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Cohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis

NCT01371071 ·Status: UNKNOWN

Immunologic Biomarker Profile of Cerebrospinal Fluid

NCT04202055 ·Status: COMPLETED

Cortical Inhibition in Patients With Multiple Sclerosis

NCT07128160 ·Status: NOT_YET_RECRUITING

Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis

NCT01250665 ·Status: UNKNOWN

Metacognition Assessment in Patient With Multiple Sclerosis

NCT04240379 ·Status: COMPLETED

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2

NCT06309173 ·Status: WITHDRAWN

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoid Dendritic Cells in Multiple Sclerosis

NCT05451069 ·Status: UNKNOWN

Prospective Investigation of Multiple Sclerosis in the Three Rivers Region

NCT02994121 ·Status: RECRUITING

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

NCT05277740 ·Status: RECRUITING

Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients

NCT01895335 ·Status: COMPLETED ·Phase: PHASE4

Study of the Intestinal Microbiota of Patients With Systemic Sclerosis

NCT04791280 ·Status: UNKNOWN

Gut Microbiota and Multiple Sclerosis

NCT03262870 ·Status: UNKNOWN

A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis

NCT01539395 ·Status: WITHDRAWN

Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment Battery

NCT02283918 ·Status: COMPLETED

Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.

NCT06395662 ·Status: ACTIVE_NOT_RECRUITING

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

NCT05663853 ·Status: COMPLETED

Multiple Sclerosis: Chi3L1 and Treatment Efficacy

NCT04289675 ·Status: COMPLETED

Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya

NCT02137707 ·Status: COMPLETED

EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

NCT02117375 ·Status: UNKNOWN ·Phase: NA

Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II

NCT03797937 ·Status: COMPLETED ·Phase: NA

Frequency of Gastrointestinal and Hepatic Manifestations Among Patients with Multiple Sclerosis, a Clinical Hospital Based Study

NCT06770959 ·Status: NOT_YET_RECRUITING